Richard Hughes

Prof. Richard Hughes

University of Michigan
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
Richard HughesRichard Hughes
Richard Hughes
CBCari R. Bryant
Cari R. Bryant
JHJanette M. Hall
Janette M. Hall
JWJason Wening
Jason Wening
LHLaura J. Huston
Laura J. Huston
RBRalph B. Blasier
Ralph B. Blasier
Anatomic factors, such as a hooked acromion, have been associated with rotator cuff disorders. Orientation of the glenoid relative to the scapula has been implicated in shoulder instability, but it has not been linked to rotator cuff disorders. The purpose of the current study was to test the hypothesis that superior inclination of the glenoid is associated with full-thickness rotator cuff tears. Glenoid inclination angles were measured from 16 shoulder radiographs of a convenience sample of eight cadavers in which one shoulder had an intact rotator cuff and the other shoulder had a full-thickness rotator cuff tear. Glenoid inclination angles for shoulders with rotator cuff tears were compared with contralateral normal shoulders using nonparametric statistical analysis. The glenoid inclination angle was greater in cadaver shoulders having full-thickness rotator cuff tears (98.6°) than in shoulders without tears (91.0°). A second experiment was done to assess the reliability of using 34 Grashey view radiographs from a clinical population to measure glenoid inclination angle. A method to measure the glenoid inclination on Grashey views was tested and was found to correlate with the inclination angles measured on cadaveric scapulae. Intrarater reliability of measurements from clinical Grashey views was 0.93, and interrater reliability was at least 0.88.

5 October 2016 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
BHBrian Hallstrom
Brian Hallstrom
BSBonita Singal
Bonita Singal
MCMark E. Cowen
Mark E. Cowen
KRKarl C. Roberts
Karl C. Roberts
Richard HughesRichard Hughes
Richard Hughes
The efficacy of tranexamic acid (TXA) in reducing blood loss and transfusion requirements in total hip and knee arthroplasty has been well established in small controlled clinical trials and meta-analyses. The purpose of the current study was to determine the risks and benefits of TXA use in routine orthopaedic surgical practice on the basis of data from a large, statewide arthroplasty registry. From April 18, 2013, to September 30, 2014, there were 23,236 primary total knee arthroplasty cases and 11,489 primary total hip arthroplasty cases completed and registered in the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI). We evaluated the association between TXA use and hemoglobin drop, transfusion, length of stay (LOS), venous thromboembolism (VTE), readmission, and cardiovascular events by fitting mixed-effects generalized linear and mixed-effects Cox models. We used inverse probability of treatment weighting to enhance causal inference. For total hip arthroplasty, TXA use was associated with a smaller drop in hemoglobin (mean difference = −0.65 g/dL; 95% confidence interval [CI] = −0.60 to −0.71 g/dL), decreased odds of blood transfusion (odds ratio [OR] = 0.72; 95% CI = 0.60 to 0.86), and decreased readmissions (OR = 0.77; 95% CI = 0.64 to 0.93) compared with no TXA use. There was no effect on VTE (hazard ratio [HR] = 0.91; 95% CI = 0.62 to 1.33), LOS (incident rate ratio [IRR] = 1.00; 95% CI = 0.97 to 1.03), or cardiovascular events (OR = 0.85; 95% CI = 0.47 to 1.52). For total knee arthroplasty, TXA was associated with a smaller drop in hemoglobin (mean difference = −0.68 g/dL; 95% CI = −0.64 to −0.71 g/dL) and one-fourth the odds of blood transfusion (OR = 0.26; 95% CI = 0.21 to 0.31). There was an association with decreased risk of VTE within 90 days after surgery (HR = 0.56; 95% CI = 0.42 to 0.73), slightly decreased LOS (IRR = 0.93; 95% CI = 0.92 to 0.95), and no association with readmissions (OR = 0.90; 95% CI = 0.79 to 1.04) or cardiovascular events (OR = 1.12; 95% CI = 0.74 to 1.71). In routine orthopaedic surgery practice, TXA use was associated with decreased blood loss and transfusion risk for both total knee and total hip arthroplasty, without evidence of increased risk of complications. TXA use was also associated with reduced risk of readmission among total hip arthroplasty patients and reduced risk of VTE among total knee arthroplasty patients, and did not have an adverse effect on cardiovascular complications in either group. Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

23 March 2017 in Current Reviews in Musculoskeletal Medicine
Verified
Journal Article
Closed access
PDF file
Richard HughesRichard Hughes
Richard Hughes
ABAditi Batra
Aditi Batra
BHBrian R. Hallstrom
Brian R. Hallstrom


22 June 2006 in Clinical Anatomy
Verified
Journal Article
Closed access
PDF file
RSR.C. Srinivasan
R.C. Srinivasan
MLM.P. Lungren
M.P. Lungren
JLJ.E. Langenderfer
J.E. Langenderfer
Richard HughesRichard Hughes
Richard Hughes

31 July 2007 in Clinical Biomechanics
Verified
Journal Article
Closed access
PDF file
CGChristopher J. Gatti
Christopher J. Gatti
CDClark Dickerson
Clark Dickerson
ECEdward K. Chadwick
Edward K. Chadwick
AMAmy G. Mell
Amy G. Mell
Richard HughesRichard Hughes
Richard Hughes